FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W15417871> ?p ?o ?g. }

• W15417871 endingPage "439" @default.
• W15417871 startingPage "432" @default.
• W15417871 abstract "Cannabinoid-based medicines have been proposed as clinically promising therapies in Parkinson's disease (PD), given the prominent modulatory function played by the cannabinoid signaling system in the basal ganglia. Supporting this pharmacological potential, the cannabinoid signaling system experiences a biphasic pattern of changes during the progression of PD. Thus, early and presymptomatic stages, characterized by neuronal malfunctioning but little evidence of neuronal death, are associated with desensitization/downregulation of CB(1) receptors. It was proposed that these losses may be part of the pathogenesis itself, since they can aggravate different cytotoxic insults which are controlled in part by cannabinoid signals, mainly excitotoxicity but also oxidative stress and glial activation. By contrast, intermediate and, in particular, advanced stages of parkinsonism characterized by a profound nigral degeneration and occurrence of major parkinsonian symptoms (e.g. bradykinesia), are associated with upregulatory responses of CB(1) receptors, possibly CB(2) receptors too, and the endocannabinoid ligands for both receptor types. This would explain the motor inhibition typical of this disease and the potential proposed for CB(1) receptor antagonists in attenuating the bradykinesia typical of PD. In addition, certain cannabinoid agonists have been proposed to serve as neuroprotective molecules in PD, given their well-demonstrated capability to reduce excitotoxicity, calcium influx, glial activation and, in particular, oxidative injury that cooperatively contribute to the degeneration of nigral neurons. However, the potential of cannabinoid-based medicines in PD have been still scarcely studied at the clinical level despite the existence of solid and promising preclinical evidence. Considering the relevance of these preclinical data, the need for finding treatments for motor symptoms that may be alternative to classic dopaminergic replacement therapy, and the lack of efficient neuroprotective strategies in PD, we believe it is of major interest to develop further studies that allow the promising expectations generated for these molecules to progress from the present preclinical evidence towards a real clinical application." @default.
• W15417871 created "2016-06-24" @default.
• W15417871 creator A5008498660 @default.
• W15417871 creator A5036189795 @default.
• W15417871 creator A5068058486 @default.
• W15417871 date "2009-12-01" @default.
• W15417871 modified "2023-10-03" @default.
• W15417871 title "Cannabinoids and Parkinsons Disease" @default.
• W15417871 cites W1568165441 @default.
• W15417871 cites W1603590524 @default.
• W15417871 cites W1927188913 @default.
• W15417871 cites W1977748966 @default.
• W15417871 cites W1986626488 @default.
• W15417871 cites W1990616075 @default.
• W15417871 cites W1992818965 @default.
• W15417871 cites W1994269884 @default.
• W15417871 cites W1994583626 @default.
• W15417871 cites W1996067881 @default.
• W15417871 cites W1998937162 @default.
• W15417871 cites W2003314029 @default.
• W15417871 cites W2004026924 @default.
• W15417871 cites W2004485518 @default.
• W15417871 cites W2009764135 @default.
• W15417871 cites W2011852660 @default.
• W15417871 cites W2015083680 @default.
• W15417871 cites W2015663165 @default.
• W15417871 cites W2015683770 @default.
• W15417871 cites W2020978550 @default.
• W15417871 cites W2027858732 @default.
• W15417871 cites W2028904201 @default.
• W15417871 cites W2030567881 @default.
• W15417871 cites W2031439839 @default.
• W15417871 cites W2032076557 @default.
• W15417871 cites W2033734808 @default.
• W15417871 cites W2034657120 @default.
• W15417871 cites W2038443115 @default.
• W15417871 cites W2038487696 @default.
• W15417871 cites W2041366408 @default.
• W15417871 cites W2043884829 @default.
• W15417871 cites W2044632947 @default.
• W15417871 cites W2052450120 @default.
• W15417871 cites W2055223069 @default.
• W15417871 cites W2056413400 @default.
• W15417871 cites W2065730117 @default.
• W15417871 cites W2074551850 @default.
• W15417871 cites W2075504851 @default.
• W15417871 cites W2077648124 @default.
• W15417871 cites W2078495330 @default.
• W15417871 cites W2082298489 @default.
• W15417871 cites W2086494508 @default.
• W15417871 cites W2090873558 @default.
• W15417871 cites W2098783607 @default.
• W15417871 cites W2106252778 @default.
• W15417871 cites W2110514788 @default.
• W15417871 cites W2110992486 @default.
• W15417871 cites W2111259863 @default.
• W15417871 cites W2111975826 @default.
• W15417871 cites W2119898593 @default.
• W15417871 cites W2120412340 @default.
• W15417871 cites W2122189667 @default.
• W15417871 cites W2125004892 @default.
• W15417871 cites W2126304984 @default.
• W15417871 cites W2136798984 @default.
• W15417871 cites W2164485911 @default.
• W15417871 cites W2167811239 @default.
• W15417871 cites W2169903789 @default.
• W15417871 cites W2171494808 @default.
• W15417871 cites W62260503 @default.
• W15417871 cites W99477398 @default.
• W15417871 cites W2131697810 @default.
• W15417871 cites W2280167861 @default.
• W15417871 doi "https://doi.org/10.2174/187152709789824642" @default.
• W15417871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19839934" @default.
• W15417871 hasPublicationYear "2009" @default.
• W15417871 type Work @default.
• W15417871 sameAs 15417871 @default.
• W15417871 citedByCount "54" @default.
• W15417871 countsByYear W154178712012 @default.
• W15417871 countsByYear W154178712013 @default.
• W15417871 countsByYear W154178712014 @default.
• W15417871 countsByYear W154178712015 @default.
• W15417871 countsByYear W154178712016 @default.
• W15417871 countsByYear W154178712017 @default.
• W15417871 countsByYear W154178712018 @default.
• W15417871 countsByYear W154178712019 @default.
• W15417871 countsByYear W154178712020 @default.
• W15417871 countsByYear W154178712021 @default.
• W15417871 countsByYear W154178712022 @default.
• W15417871 countsByYear W154178712023 @default.
• W15417871 crossrefType "journal-article" @default.
• W15417871 hasAuthorship W15417871A5008498660 @default.
• W15417871 hasAuthorship W15417871A5036189795 @default.
• W15417871 hasAuthorship W15417871A5068058486 @default.
• W15417871 hasConcept C126322002 @default.
• W15417871 hasConcept C148001335 @default.
• W15417871 hasConcept C169760540 @default.
• W15417871 hasConcept C170493617 @default.
• W15417871 hasConcept C25498285 @default.

• next